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Breast hamartoma is a relatively rare entity with an incidence of
approximately 0.7% of benign breast masses. Hamartomas may
become large and cause breast asymmetry. Hamartomas, although
benign, have the potential for malignant transformation and should
be treated or monitored closely when encountered especially if
microcalciﬁcations or speculated lesions are seen within the mass.
The following cases demonstrate two of the largest documented
harmartomas since they were recognized as distinct entities in the
early 1970's. Proper referral to the appropriate specialists can result
in earlier detection and resolution of symptoms.
© 2014 The Authors. Published by Elsevier Ltd on behalf of British
Association of Plastic, Reconstructive and Aesthetic Surgeons. This
is an open access article under the CC BY-NC-SA license (http://
creativecommons.org/licenses/by-nc-sa/4.0/).Introduction
Breast asymmetry can be caused by multiple pathophysiologic etiologies, benign or malignant, and
care must be taken during workup as management will differ depending on etiology. There are many
benign causes ranging from physiologic changes to rare congenital anomalies. Some reverse with time
and medical management, while others necessitate surgical intervention. In this review, we focus on
the presentation of hamartomas as a cause of breast asymmetry and highlight its importance in the
differential for early intervention.fax: þ1 806 743 1475.
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S. Cazorla, C. Arentz / JPRAS Open 3 (2015) 17e2118Breast hamartoma is a rare entity with an incidence of approximately 0.7%1,2 of benign breast
masses. Hamartomas slowly enlarge resulting in breast asymmetry and may cause compressive
symptoms resulting in signiﬁcant discomfort and lymphedema. Historically, hamartomas have been
noted as important to identify as a separate entity due to assumed increased potential for malignant
transformation. The cases presented below demonstrate why breast hamartoma must be kept in the
differential of breast asymmetry and shed some new light on previously assumed increased malignant
potential of these benign lesions. The following cases demonstrate two of the largest documented
hamartomas since they were recognized as distinct entities in the early 1970's.
Case 1
The ﬁrst patient is a 25-year-old female who presented to her gynecologist for routine exam at 18
and was started on oral contraceptives for birth control. Soon afterwards, she noticed signiﬁcant
unilateral left breast enlargement. She returned to the gynecologist multiple times for evaluation of her
obvious breast asymmetry which resulted in breast ultrasounds demonstrating benign appearing
breast tissue. She was told her breast growth was normal development. At 25, after seven years, she
was referred to a plastic surgeon for augmentation of her right breast to match her signiﬁcantly larger
left breast (Figure 1A). Upon evaluation by the plastic surgeon she was referred to our breast clinic.
Upon initial presentation, a space occupying mass was suspected and ultrasound was performed
noting a mass. MRI results suggested what appeared to be a giant left-sided breast hamartomaFigure 1. A. Preoperative photo of left breast hamartoma. B. Preoperative MRI suggesting giant left-sided breast hamartoma. C. Gross
resection of left breast hamartoma. D. Postoperative photo after removal of left breast hamartoma.
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entire 15 cm  13 cm mass was removed en bloc and weighed 450 g (1 lb) (Figure 1C). Post-surgical
recovery was uneventful and re-expansion of her normal breast tissue led to no additional recon-
structive surgery (Figure 1D). Histological evaluation was consistent with breast hamartoma.
Case 2
The second patient is a 58-year-old female with a debilitating fear of the healthcare system. She had
a right-sided breast mass, which had increased in size over ten years. Upon presentation, she had been
experiencing signiﬁcant pain and debilitation due to the size and weight of the mass (Figure 2A). She
had never had a mammogram. The mass was biopsied showing a 20 cm complex ﬁbroadenoma and
imaging suggested a well circumscribed mass. She had a right partial mastectomy removing a 1497 g
(3.3 lb) mass, which depicted hamartoma on histopathology (Figure 2B).
Discussion
Differential diagnosis for benign causes of breast asymmetry may include lipoma, lymphatic or
vascular malformation, adenoma, fat necrosis, mucocele, myoﬁbroblastoma, adenomyoepithelioma,
phyllodes cyst, cystadenoma, leiomyoma, abscess, and hamartoma. Breast asymmetry can cause life-
long psychosocial impact possibly resulting in low self-esteem and interfering with interpersonal re-
lationships, especially if not ﬁrst recognized in adolescence or young adulthood when relationship
dynamics are being established. Adequate initial assessment including careful history and physical
exam taking into account patient age and family history are the initial steps in any patient evaluation
and are no less important in theworkup of thosewho present with breast asymmetry. This initial phase
of investigation will often lead to ultrasound, mammogram and/or ﬁne-needle aspiration (FNA) and
reveal more common causes of asymmetry such as physiologic changes from hormone ﬂuctuation, fat
necrosis from trauma, abscess, or ﬁbroadenoma. When initial workup fails to reveal a more common
etiology and benign mass is still suspected, hamartoma should remain in the patient's differential
diagnosis (Figures 3 and 4).
Hamartoma of the breast is a rare lesion, which often goes unrecognized by pathologists due to its
resemblance to other benign and physiological changes of the breast. The average size of breast
hamartomas on presentation is 2.8 cm.3 Typical presentation is in the third to ﬁfth decade of life, and
most are discovered during physical exam revealing a soft ﬁrm palpable and mobile mass.1,4Figure 2. A. Preoperative photo of right breast hamartoma. B. Gross resection of right breast hamartoma.
Figure 3. Gross resection of right breast hamartoma.
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with varying amounts of ﬁbrous to adipose tissue content with a pseudocapsule.5 They are classically
described as oval or lentiform masses which are well circumscribed with radiolucent areas repre-
senting adipose tissue and dense areas which correspond to ﬁbroglandular tissue surrounded by a
dense pseudocapsule.3,4,6 Similar ﬁndings are seen with MRI, which demonstrate an encapsulated
mass with heterogeneous appearance. Due to the variable amount of ﬁbrofatty content causing a varied
sonographic appearance there is little to no role of ultrasonography in the diagnosis of this lesion.7
This was the case with our patient; the mass was encompassing the entirety of the breast so the
ultrasound was read as “normal tissue”. Tse et al (2002) evaluated the use of FNA in the diagnosis of
breast hamartoma. The group reviewed the pathology of 14 patients with either FNA or core needle
biopsy. None of the FNA or core needle samples diagnosed hamartoma. Although the study sample size
was small, it indicates that the role of percutaneous biopsy for diagnosis of hamartoma is limited.
Pathologic description is poorly deﬁned. The original deﬁnition was of a “clinically discrete nodule
composed of variable amounts of epithelial elements in a ﬁbrofatty stroma”.3
Hamartomas are identiﬁed as clinically separate from ﬁbroadenomas due to the presence of ducts
and lobules. There is a small incidence of approximately 0.1% of malignancy found withinFigure 4. Closer view of hamartoma.
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entity was ﬁrst deﬁned in 1971.8 The majority of cancers discovered were ductal carcinoma.9 Tse et al
conducted a large review of breast hamartomas and found the median age of patients with completely
benignmasses was 37.8. Themedian age of patients withmalignancy within the hamartomawas 58.2.9
Masses of 5.8 cm or more were more likely to have malignant transformation.3 It is likely that carci-
noma arising from a breast hamartoma is a coincidental ﬁnding due to the presence of all the con-
stituents of normal breast tissue within the lesion.9
The evaluation of breast asymmetry the diagnosis of breast hamartoma is best made with high
clinical suspicion and radiologic correlation by MRI or mammography to avoid misdiagnosis. Surgical
excision is the deﬁnitive treatment. Hamartomas have the same malignant potential as normal breast
tissue, unless greater than 6 cm, and thus do not require any additional treatment than one would for
adenoma or other benign lesions. However, there is the potential for signiﬁcant growth and breast
deformity, which can have lasting psychosocial implications. In case 1, our patient suffered for seven
years with her breast mass before diagnosis. Another report noted a women was undiagnosed for 30
years and suffered signiﬁcant morbidity including ipsilateral lymphedema due to the same benign and
easily rectiﬁed disease.10 There is limited training in differential diagnosis for breast asymmetry
outside of specialized ﬁelds, proper education to general practioners and primary care physicians is
essential. Recognition of potentially reversible conditions early will result in proper management,
decreased morbidity, and diminished psychosocial sequelae.
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